AIM ImmunoTech Inc (AIM)
0.438
+0.01
(+1.86%)
USD |
NYAM |
Apr 25, 10:29
AIM ImmunoTech Price to Book Value: 2.290 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.248 |
| April 23, 2024 | 2.224 |
| April 22, 2024 | 2.196 |
| April 19, 2024 | 2.431 |
| April 18, 2024 | 2.493 |
| April 17, 2024 | 2.487 |
| April 16, 2024 | 2.588 |
| April 15, 2024 | 2.534 |
| April 12, 2024 | 2.938 |
| April 11, 2024 | 3.210 |
| April 10, 2024 | 2.917 |
| April 09, 2024 | 2.583 |
| April 08, 2024 | 2.555 |
| April 05, 2024 | 2.573 |
| April 04, 2024 | 2.770 |
| April 03, 2024 | 2.490 |
| April 02, 2024 | 2.353 |
| April 01, 2024 | 2.562 |
| March 28, 2024 | 2.462 |
| March 27, 2024 | 2.316 |
| March 26, 2024 | 2.258 |
| March 25, 2024 | 2.264 |
| March 22, 2024 | 2.282 |
| March 21, 2024 | 1.96 |
| March 20, 2024 | 2.058 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.083 |
| March 18, 2024 | 1.929 |
| March 15, 2024 | 1.698 |
| March 14, 2024 | 1.716 |
| March 13, 2024 | 1.852 |
| March 12, 2024 | 1.826 |
| March 11, 2024 | 1.852 |
| March 08, 2024 | 1.945 |
| March 07, 2024 | 1.975 |
| March 06, 2024 | 2.004 |
| March 05, 2024 | 2.032 |
| March 04, 2024 | 2.032 |
| March 01, 2024 | 2.061 |
| February 29, 2024 | 2.063 |
| February 28, 2024 | 2.063 |
| February 27, 2024 | 2.110 |
| February 26, 2024 | 2.109 |
| February 23, 2024 | 2.148 |
| February 22, 2024 | 2.083 |
| February 21, 2024 | 2.135 |
| February 20, 2024 | 2.161 |
| February 16, 2024 | 1.950 |
| February 15, 2024 | 2.006 |
| February 14, 2024 | 2.091 |
| February 13, 2024 | 2.058 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2295
Minimum
Oct 29 2019
12.31
Maximum
Mar 09 2020
1.488
Average
1.070
Median
Dec 01 2023
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 12.84 |
| Protalix BioTherapeutics Inc | 2.546 |
| Electromed Inc | 3.424 |
| Xtant Medical Holdings Inc | 2.257 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 105.35 |
| PEG Ratio | -0.0146 |
| Price | 0.438 |
| Earnings Yield | -137.0% |
| Market Cap | 21.86M |
| PEGY Ratio | -0.0146 |